Susquehanna International Group
HARP

Susquehanna International Group’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Susquehanna International Group’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,630
Closed -$81K – 14334
2022
Q1 		$81K Sell
1,630
-1,450
-47% -$75.2K ﹤0.01% 12049
2021
Q4 		$233K Sell
3,080
-2,760
-47% -$188K ﹤0.01% 11117
2021
Q3 		$461K Sell
5,840
-970
-14% -$97.5K ﹤0.01% 9608
2021
Q2 		$945K Buy
6,810
+2,030
+42% +$387K ﹤0.01% 7929
2021
Q1 		$1M Sell
4,780
-5,920
-55% -$1.19M ﹤0.01% 7745
2020
Q4 		$1.78M Buy
10,700
+4,800
+81% +$742K ﹤0.01% 5341
2020
Q3 		$1M Buy
+5,900
New +$851K ﹤0.01% 6113

Susquehanna International Group's HARP Position: Q2 2023 in Review

Susquehanna International Group sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2023, closing a stake of 5,395 shares — an estimated $40.1K sold.

Susquehanna International Group first reported a position in HARP in Q3 2020 and held it in 10 quarters. The position peaked at $1.9M in Q1 2021. 44 funds tracked by Wall St. Rank hold HARP as of Q2 2023.

  • Susquehanna International Group reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 5,395 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $40.1K.
  • Susquehanna International Group first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2020 and held it in 10 quarters.
  • Susquehanna International Group's Harpoon Therapeutics, Inc. Common Stock position peaked at $1.9M in Q1 2021.
  • 44 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.